{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T06:10:12Z","timestamp":1759903812861,"version":"build-2065373602"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/s0378-4274(23)00823-8","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T23:41:50Z","timestamp":1693957310000},"page":"S244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["P21-16: Preconditioning MSCs with IFN-\u03b3 as a promising therapeutic strategy towards COVID-19-induced neurological damage"],"prefix":"10.1016","volume":"384","author":[{"given":"C.M.","family":"Trigo","sequence":"first","affiliation":[]},{"given":"S.P.","family":"Cam\u00f5es","sequence":"additional","affiliation":[]},{"given":"A.S.","family":"Serras","sequence":"additional","affiliation":[]},{"given":"M.","family":"Gava","sequence":"additional","affiliation":[]},{"given":"R.","family":"Vitorino","sequence":"additional","affiliation":[]},{"given":"A.R.","family":"Vaz","sequence":"additional","affiliation":[]},{"given":"D.","family":"Brites","sequence":"additional","affiliation":[]},{"given":"S.","family":"Sol\u00e1","sequence":"additional","affiliation":[]},{"given":"J.P.","family":"Miranda","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/S0378-4274(23)00823-8_bib1","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/s41591-022-02028-2","article-title":"How COVID-19 shaped mental health: from infection to pandemic effects","volume":"28","author":"Phennix","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/S0378-4274(23)00823-8_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaci.2020.10.008","article-title":"COVID-19-associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome-the superantigen hypothesis","volume":"147","author":"Noval Rivas","year":"2021","journal-title":"Allergy Clin Immunol"},{"key":"10.1016\/S0378-4274(23)00823-8_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2019.00018","article-title":"The secretome derived from 3D-cultured umbilical cord tissue MSCs counteracts manifestations typifying rheumatoid arthritis","volume":"10","author":"Miranda","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/S0378-4274(23)00823-8_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jare.2022.01.013","article-title":"3D-MSCs A151 ODN-loaded exosomes are immunomodulatory and reveal a proteomic cargo that sustains wound resolution","volume":"41","author":"Cam\u00f5es","year":"2022","journal-title":"J Adv Res."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427423008238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427423008238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:29:38Z","timestamp":1759901378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427423008238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":4,"alternative-id":["S0378427423008238"],"URL":"https:\/\/doi.org\/10.1016\/s0378-4274(23)00823-8","relation":{},"ISSN":["0378-4274"],"issn-type":[{"type":"print","value":"0378-4274"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P21-16: Preconditioning MSCs with IFN-\u03b3 as a promising therapeutic strategy towards COVID-19-induced neurological damage","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0378-4274(23)00823-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}